NASDAQ:KOD • US50015M1099
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KODIAK SCIENCES INC (KOD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-27 | UBS | Maintains | Buy -> Buy |
| 2026-03-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-02-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-01-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-07 | UBS | Initiate | Buy |
| 2025-11-17 | Chardan Capital | Maintains | Neutral -> Neutral |
| 2025-11-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-11 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-10-24 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-10-23 | LifeSci Capital | Initiate | Outperform |
| 2025-10-06 | Chardan Capital | Maintains | Neutral -> Neutral |
| 2025-09-25 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2025-09-22 | Jefferies | Initiate | Buy |
| 2025-08-18 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-08-14 | Barclays | Maintains | Underweight -> Underweight |
| 2025-08-14 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-09 | Jefferies | Upgrade | Hold -> Buy |
| 2024-11-15 | Barclays | Maintains | Underweight -> Underweight |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-09-24 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-09-05 | HC Wainwright & Co. | Initiate | Neutral |
| 2024-04-04 | UBS | Maintains | Neutral -> Neutral |
| 2024-04-01 | Barclays | Maintains | Underweight -> Underweight |
| 2023-12-21 | UBS | Maintains | Neutral -> Neutral |
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 271.59% | N/A 44.82% | N/A 61.58% | N/A 39.89% | N/A 23.64% | N/A 14.92% | |||||||||||
| EBITDA YoY % growth | -16.89M | -24.97M -47.84% | -25.88M -3.64% | -48.65M -87.98% | -135.53M -178.58% | -266.05M -96.30% | -337.58M -26.89% | -259.023M 23.27% | -168.139M 35.09% | -216.06M -28.50% | N/A -10.05% | N/A 6.27% | N/A 88.01% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -17.15M | -25.52M -48.80% | -26.37M -3.33% | -49.19M -86.54% | -136.01M -176.50% | -267.05M -96.35% | -341.38M -27.83% | -277.321M 18.76% | -186.849M 32.62% | -234.388M -25.44% | N/A -13.55% | N/A -0.87% | N/A 48.29% | N/A 59.25% | N/A 324.72% | N/A 151.33% | N/A 49.71% | N/A 25.66% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.25 40.14% | -2.89 -131.20% | -5.15 -78.20% | -6.39 -24.08% | -4.96 22.38% | -3.36 32.26% | -4.32 -28.57% | N/A 13.54% | N/A 5.42% | N/A 66.36% | N/A 51.56% | N/A 296.49% | N/A 144.64% | N/A 47.45% | N/A 24.26% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -1.02 6.18% | -0.96 6.45% | -0.95 17.81% | -0.94 10.07% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -57.272M -8.94% | -58.176M -25.61% | -60.474M -24.51% | -63.499M -62.30% |
| EBIT Q2Q % growth | -58.44M -2.22% | -58.385M -5.18% | -61.833M 0.83% | -62.719M -9.17% |
All data in USD
11 analysts have analysed KOD and the average price target is 56.71 USD. This implies a price increase of 25.5% is expected in the next year compared to the current price of 45.19.
KODIAK SCIENCES INC (KOD) will report earnings on 2026-05-12.
The consensus EPS estimate for the next earnings of KODIAK SCIENCES INC (KOD) is -1.02 USD and the consensus revenue estimate is 0 USD.